M86.3

Clinical Causes: The exact cause of CMO remains unclear, but it is believed to involve an abnormal immune response that results in inflammation within the bones. In some cases, infections may trigger or contribute to the condition, but many patients do not have a clear infectious cause. Genetic and environmental factors may also play a role, although research is ongoing to fully understand the risk factors.

Key Symptoms: Persistent bone pain, often worsening with activity Swelling and tenderness in affected areas Localized warmth over the affected bones Reduced range of motion or stiffness in nearby joints Fever is less common but can occur in some cases Fatigue and malaise might accompany systemic symptoms

Diagnosis Path: Diagnosing CMO involves a combination of clinical evaluation, imaging studies, and laboratory tests. - **Medical History & Physical Examination:** The healthcare provider assesses symptoms and looks for signs of inflammation or swelling. - **Imaging Tests:** MRI is often used to detect bone inflammation and differentiate CMO from infections or other bone diseases. X-rays may show bone changes over time. - **Laboratory Tests:** Blood tests can help identify inflammation markers like elevated ESR or CRP levels, but these are non-specific. - **Biopsy:** In some cases, a bone biopsy is performed to rule out infection or another condition and to confirm the diagnosis.

Treatment Protocols: Managing CMO typically involves a multidisciplinary approach aimed at reducing inflammation, relieving pain, and improving function. - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to decrease inflammation and pain. In some cases, corticosteroids or other immunosuppressive medications may be prescribed. - **Physical Therapy:** Exercises and physical therapy can help maintain joint flexibility and muscle strength. - **Surgical Intervention:** Rarely, surgery is needed to remove damaged tissue or to correct deformities if the disease progresses. - **Monitoring and Support:** Regular follow-up is essential to monitor disease progression and response to treatment. Because CMO is a chronic condition, management often focuses on controlling symptoms and maintaining quality of life through coordinated care.